Choose a country to view content specific to your location
Choose a country to view content specific to your location
Recombinant antigens are used increasingly over native allergen extracts in the diagnosis of allergies. They are capable of binding IgE antibodies in a comparable way to natural allergens, and they demonstrate good reactivity in in-vitro diagnostic tests. Meridian’s panel of recombinant allergens is ideally suited to developing quantitative allergy ELISA tests that can determine an individual’s specific IgE profile.
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |
